| Record Information |
| Version |
3.5 |
| Creation Date |
2009-01-30 02:59:52 -0700 |
| Update Date |
2013-05-29 13:46:30 -0600 |
| HMDB ID |
HMDB11627 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Farnesylcysteine |
| Description |
In patients with chronic fatigue syndrome (CFS) we found increased IgM levels to S-farnesyl-L-cysteine. S-farnesyl-L-cysteine plays a key role in regulating cell growth, differentiation and apoptosis through RAS protein activity. The latter depends on their anchorage to the inner surface of the plasma membrane, which is promoted by their common carboxy-terminal S-farnesyl-cysteine. The presence of antibodies to S-farnesyl-L-cysteine suggest that RAS functions may have undergone damage by oxidative/nitrosative stress, causing disturbed functional activity in the regulation of cell growth. (PMID 17159817 ). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- (E,E)-L-S-(3,7,11-trimethyl-2,6,10-dodecatrienyl)-Cysteine
- Farnesylcysteine
- S-All-trans-Farnesyl-L-cysteine
- S-trans-trans-Farnesylcysteine
- S-[(2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl]-L-Cysteine
- S-[(2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrienyl]-L-Cysteine,(9CI)
|
| Chemical Formula |
C18H31NO2S |
| Average Molecular Weight |
325.509 |
| Monoisotopic Molecular Weight |
325.207549931 |
| IUPAC Name |
(2R)-2-amino-3-{[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]sulfanyl}propanoic acid |
| Traditional IUPAC Name |
(2R)-2-amino-3-{[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]sulfanyl}propanoic acid |
| CAS Registry Number |
68000-92-0 |
| SMILES |
N[C@@H](CSC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=O |
| InChI Identifier |
InChI=1S/C18H31NO2S/c1-14(2)7-5-8-15(3)9-6-10-16(4)11-12-22-13-17(19)18(20)21/h7,9,11,17H,5-6,8,10,12-13,19H2,1-4H3,(H,20,21)/b15-9+,16-11+/t17-/m0/s1 |
| InChI Key |
SYSLNQMKLROGCL-BCYUYYMPSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Amino Acids, Peptides, and Analogues |
| Class |
Amino Acids and Derivatives |
| Sub Class |
Alpha Amino Acids and Derivatives |
| Other Descriptors |
- Aliphatic Acyclic Compounds
- Sesquiterpenes
|
| Substituents |
- Acyclic Alkene
- Carboxylic Acid
- Isoprene
- Primary Aliphatic Amine (Alkylamine)
- Thioether
|
| Direct Parent |
Alpha Amino Acids and Derivatives |
| Ontology |
| Status |
Expected and Not Quantified |
| Origin |
|
| Biofunction |
Not Available
|
| Application |
Not Available
|
| Cellular locations |
Not Available
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
Not Available |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
Not Available
|
| Biological Properties |
| Cellular Locations |
Not Available
|
| Biofluid Locations |
Not Available
|
| Tissue Location |
Not Available
|
| Pathways |
Not Available
|
| Normal Concentrations |
|
Not Available |
| Abnormal Concentrations |
|
Not Available |
| Associated Disorders and Diseases |
| Disease References |
None |
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
Not Available |
| DrugBank Metabolite ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB028328 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
4942854  |
| KEGG Compound ID |
C19691  |
| BioCyc ID |
Not Available |
| BiGG ID |
Not Available |
| Wikipedia Link |
Not Available |
| NuGOwiki Link |
HMDB11627  |
| Metagene Link |
HMDB11627  |
| METLIN ID |
Not Available |
| PubChem Compound |
6438372  |
| PDB ID |
Not Available |
| ChEBI ID |
62141  |
| References |
| Synthesis Reference |
Not Available |
| Material Safety Data Sheet (MSDS) |
Not Available
|
| General References |
- Maes M, Mihaylova I, Leunis JC: Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins. Neuro Endocrinol Lett. 2006 Oct;27(5):615-21.
Pubmed: 17159817
- Lamango NS, Charlton CG: Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats. Pharmacol Biochem Behav. 2000 Aug;66(4):841-9.
Pubmed: 10973524
- Havel CM, Fisher P, Watson JA: Isopentenoid synthesis in embryonic Drosophila cells: prenylated protein profile and prenyl group usage. Arch Biochem Biophys. 1992 Jun;295(2):410-20.
Pubmed: 1586169
- Aharonson Z, Gana-Weisz M, Varsano T, Haklai R, Marciano D, Kloog Y: Stringent structural requirements for anti-Ras activity of S-prenyl analogues. Biochim Biophys Acta. 1998 Feb 27;1406(1):40-50.
Pubmed: 9545527
- Elad G, Paz A, Haklai R, Marciano D, Cox A, Kloog Y: Targeting of K-Ras 4B by S-trans,trans-farnesyl thiosalicylic acid. Biochim Biophys Acta. 1999 Dec 9;1452(3):228-42.
Pubmed: 10590312
- Volker C, Miller RA, McCleary WR, Rao A, Poenie M, Backer JM, Stock JB: Effects of farnesylcysteine analogs on protein carboxyl methylation and signal transduction. J Biol Chem. 1991 Nov 15;266(32):21515-22.
Pubmed: 1939182
|